Clinical Trials Insight: 700040345
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2009
At a glance
- Drugs VX 500 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Vertex Pharmaceuticals
- 07 Jan 2009 New trial record.
- 27 Oct 2008 Status changed from planning to recruiting, according to a Vertex media release.